Indeed, associations with high-OGT levels and an enhanced grade of tumor aggressiveness, heightened metastasis incidence, and poor prognosis were also identified in numerous cancers, including prostate [11], colorectal [12], ovary [13], breast [14], endometrium [15], pancreatic [16], and bladder cancers [17]. Here, OGT is linked to neoplasm.